Endocrine Abstracts

The significance of hyperandrogenism (HA) as a metabolic risk factor in women is controversial. HA can be defined as either clinical (hirsutism) or biochemical (elevated androgen levels). We aimed to investigate whether HA at age 31 associates with metabolic syndrome (MetS), type 2 diabetes mellitus (DM2) or carotid intima media thickness (CIMT) by age 46. In a prospective, general population-based follow-up birth cohort (n=5889 women) blood samples were collected at ...

Introduction: PCOS-related hormonal and metabolic alterations seem to persist later in life. The aim was to investigate age-related hormonal and metabolic parameters in PCOS and in healthy women in order to determine cut-off values predicting PCOS.Subjects and methods: PCOS women and 230 healthy controls were divided accordingly: 18–24, 25–29, 30–34, 35–39, 40–44, 45–49 and >50 years. A particular interest was to analyze...

It has been reported that women with polycystic ovary syndrome (PCOS) show cardiovascular autonomic dysfunction, with reduced parasympathetic (vagal) and increased sympathetic activity, which are known to be independent risk factors for cardiovascular morbidity and mortality. However, it is not yet clear if PCOS per se leads to cardiovascular autonomic dysfunction independently of metabolic abnormalities. In a prospective, general population-based follow-up birth coho...

Background: The age at adiposity rebound (AR), at which BMI begins to rise after infancy around the age of 5 years, is associated with obesity and metabolic alteration in later life. Given that polycystic ovary syndrome (PCOS) has strong metabolic components, early growth patterns could reveal predisposition for PCOS. Thus, we aimed to investigate the associations of growth trajectories from birth to puberty with PCOS diagnosis,vbody composition and hyperandrogenism later in a...